Delivery Order 36F79725D0146-36C24526N0671
Award Date 6/23/26
Potential Completion Date 6/24/26
Potential Value $23K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Carrollton, TX 75010, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Veterans Integrated Service Network 5 issued a $22,508.03 delivery order to Merck Sharp & Dohme LLC on June 12, 2026, for belzutifan 40 mg, with an ultimate completion date of June 16, 2026. The order is issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), a $5.84 billion schedule contract with the Department of Veterans Affairs extending through May 31, 2030. Place of performance is Carrollton, TX. The order is priced on a firm fixed price basis and carries no...
- <p>The Department of Veterans Affairs, Veterans Integrated Service Network 5, issued a $22,508.03 delivery order to Merck Sharp & Dohme LLC on June 12, 2026, for Welireg (belzutifan) 40 mg under the Federal Supply Schedule contract for Pharmaceuticals and Drugs (FSS-61-IB).</p> <p>Place of performance is Carrollton, TX. The order is firm fixed price with an ultimate completion date of June 15, 2026. No set-aside was used.</p>
- This federal contract award is for the delivery of Belzutifan (Welireg) 40 mg, a pharmaceutical product, to the U.S. Department of Veterans Affairs (VA). The contract was awarded to Merck Sharp & Dohme LLC, doing business as Merck, a major pharmaceutical manufacturer and supplier to the federal government. The contract is a Delivery Order under Merck's Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs. It has a firm fixed price of $19,964.86 and a completion date of...
- The Department of Veterans Affairs Veterans Health Administration awarded a $19,964.86 firm-fixed-price delivery order contract to Merck Sharp & Dohme LLC, doing business as Merck, for the pharmaceutical drug Welireg (Belzutifan) 40mg tablets. This award is under Merck's existing General Services Administration Federal Supply Schedule (FSS-61-IB) contract for pharmaceuticals and drugs. The contract has a completion date of June 7, 2024. Merck is a major pharmaceutical manufacturer that has...
- This is a firm fixed-price delivery order awarded by the Veterans Integrated Service Network 21 (VISN 21) of the U.S. Department of Veterans Affairs to Merck Sharp & Dohme LLC, doing business as Merck, a major pharmaceutical manufacturer. The order is for the drug Welireg (belzutifan) 40mg tablets, National Drug Code 00006-5331-01. The award has a ceiling value of $19,964.86 and an ultimate completion date of July 10, 2024. This delivery order falls under Merck's prime contract on the...
- The U.S. Department of Veterans Affairs (VA) awarded a Delivery Order contract to Merck Sharp & Dohme LLC (doing business as Merck), a major pharmaceutical manufacturer, for the supply of Welireg (belzutifan) 40mg tablets. The contract has a ceiling value of $19,964.86 and a completion date of January 30, 2025. The contract was awarded on December 30, 2024 and does not have a set-aside designation. Merck holds an Indefinite Delivery Vehicle (IDV) Blanket Purchase Agreement with the VA for...
- The Veterans Integrated Service Network 2 awarded a firm fixed-price purchase order valued at $22.5K to ASD Specialty Healthcare, LLC (doing business as AmerisourceBergen) on January 9, 2026, for patient-specific pharmacy procurement of Belzutifan 40mg. Belzutifan (marketed as Welireg) is an FDA-approved oncology medication used to treat renal cell carcinoma and other cancers. The contract has no set-aside designation and will be performed in West Chester Township, Ohio, with an ultimate...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 1 awarded a $11,317.97 delivery order to Janssen Biotech, Inc. for BALVERSA medication. The contract was issued against the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), with a firm fixed price and performance period through December 31, 2021. No set-aside designation was applied. Janssen Biotech, Inc. will provide BALVERSA medication to support healthcare services for...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 2 awarded a $11,317.97 delivery order to Janssen Biotech, Inc. for BALVERSA 3MG tablets. The tablets will be delivered under firm fixed price terms to a location in Frisco, Texas by August 5, 2020. The contract was awarded utilizing the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), a multiple award schedule managed by the General Services Administration, which provides access to...
- <p>Veterans Integrated Service Network 5 issued a delivery order to UCB Pharma, Inc. on June 18, 2026, for Zilbrysq 32.4 MG with a ceiling value of $31,040.96 under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The order is firm fixed price with no set-aside.</p> <p>Place of performance is Pittsburgh, PA 15205. The ultimate completion date is June 22, 2026.</p>